TrialPanorama/TrialPanorama-database huggingface dataset:
Study 9718903 — Surrogate Endpoint (SUR): Bone mineral density
Study 9718903 — Surrogate Endpoint (SUR): Serum calcium
Study 24172719 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18382886 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 18382886 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18382886 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20736443 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16093744 — Surrogate Endpoint (SUR): Blood pressure
Study 12613016 — Surrogate Endpoint (SUR): Serum testosterone
Study 9094889 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17960793 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 10892762 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study 8751522 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 8751522 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 24419415 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 9710889 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7822588 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 28063515 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19118379 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study 16099893 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 11704367 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 29605500 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study 29605500 — Predictive Biomarker (PRD): PRSS27 mRNA
Genes: PRSS27; MPN; UNQ1884/PRO4327
Study 23206923 — Surrogate Endpoint (SUR): Blood pressure
Study 23206923 — Surrogate Endpoint (SUR): Serum sodium
Study 21672334 — Surrogate Endpoint (SUR): Bone mineral density
Study 19364334 — Predictive Biomarker (PRD): VIT mRNA
Genes: VIT; UNQ647/PRO1277
Study 16394086 — Surrogate Endpoint (SUR): Blood pressure
Study 11096165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9116923 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9116923 — Surrogate Endpoint (SUR): Blood pressure
Study 26277172 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22612371 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 10393397 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10393397 — Surrogate Endpoint (SUR): Blood pressure
Study 31116848 — Surrogate Endpoint (SUR): Blood pressure
Study 21859266 — Surrogate Endpoint (SUR): Forced vital capacity
Study 15488877 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15488877 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8163828 — Predictive Biomarker (PRD): PYCARD mRNA
Genes: PYCARD; ASC; CARD5; TMS1
Study 6546806 — Surrogate Endpoint (SUR): Bacterial count
Study 31026738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31026738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29136476 — Surrogate Endpoint (SUR): Blood pressure
Study 27620390 — Surrogate Endpoint (SUR): Blood pressure
Study 25496165 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 18539106 — Surrogate Endpoint (SUR): Bone mineral density
Study 10557173 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 2104681 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 318736 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 16543909 — Surrogate Endpoint (SUR): Blood pressure
Study 9763797 — Surrogate Endpoint (SUR): Blood pressure
Study 21823172 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31294485 — Predictive Biomarker (PRD): TXNRD3 mRNA
Genes: TXNRD3; TGR; TRXR3
Study 20068559 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20068559 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20068559 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23150693 — Predictive Biomarker (PRD): UCP3 mRNA
Genes: UCP3; SLC25A9
Study 17027571 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17027571 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 17027571 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 27379911 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 27379911 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 27379911 — Safety Biomarker (SAF): Vitamin K-dependent protein C
Genes: PROC
Study 23970206 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20513750 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 18791928 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 18791928 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 3882063 — Surrogate Endpoint (SUR): Serum creatinine
Study 21566200 — Predictive Biomarker (PRD): MBTPS1 mRNA
Genes: MBTPS1; KIAA0091; S1P; SKI1
Study 21566200 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21566200 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 11799082 — Surrogate Endpoint (SUR): Blood pressure
Study 29353627 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 24970721 — Surrogate Endpoint (SUR): Blood pressure
Study 24361227 — Predictive Biomarker (PRD): Solute carrier family 29 member 1
Genes: SLC29A1; ENT1
Study 24361227 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study 15549277 — Surrogate Endpoint (SUR): Blood pressure
Study 11544435 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9333880 — Surrogate Endpoint (SUR): Bone mineral density
Study 3593901 — Surrogate Endpoint (SUR): Blood pressure
Study 30647815 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 30647815 — Safety Biomarker (SAF): Reactive oxygen species
Study 30647815 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 24828850 — Surrogate Endpoint (SUR): Blood pressure
Study 22397953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22397953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22397953 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 8419695 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8419695 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 8419695 — Safety Biomarker (SAF): Interleukin 1
Study 8419695 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 30497077 — Surrogate Endpoint (SUR): Blood pressure
Study 25223173 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 17672075 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 11782647 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9825249 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 31538703 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 19444280 — Surrogate Endpoint (SUR): Blood pressure
Study 16762125 — Surrogate Endpoint (SUR): Blood pressure
Study 9457607 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30561638 — Predictive Biomarker (PRD): AHRR mRNA
Genes: AHRR; BHLHE77; KIAA1234
Study 28019091 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 28019091 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 25852210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25852210 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 25852210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19351624 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11257323 — Surrogate Endpoint (SUR): Blood pressure
Study 8361609 — Surrogate Endpoint (SUR): Blood pressure
Study 25402562 — Surrogate Endpoint (SUR): Blood pressure
Study 7867237 — Surrogate Endpoint (SUR): Blood pressure
Study 31266155 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 21736770 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 18817989 — Surrogate Endpoint (SUR): Forced vital capacity
Study 15801991 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15801991 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20642555 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 24356595 — Surrogate Endpoint (SUR): Blood pressure
Study 22844471 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 12375299 — Surrogate Endpoint (SUR): Blood pressure
Study 27423432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27423432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30924165 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 28668524 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 28668524 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28668524 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28668524 — Safety Biomarker (SAF): IL-6 and IL-10
Study 22725663 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 17050564 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 25670636 — Surrogate Endpoint (SUR): Serum creatinine
Study 24402637 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 21334753 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 21334753 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21334753 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16749654 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10790552 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 8988065 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 6652642 — Surrogate Endpoint (SUR): Blood pressure
Study 30902820 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 30902820 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 30902820 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30902820 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 22994867 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 22994867 — Predictive Biomarker (PRD): FURIN mRNA
Genes: FURIN; FUR; PACE; PCSK3
Study 23382519 — Predictive Biomarker (PRD): IFT122 mRNA
Genes: IFT122; SPG; WDR10; WDR140
Study 19159726 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 17573989 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1979522 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 17298973 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 11149999 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 29517580 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22746337 — Surrogate Endpoint (SUR): Blood pressure
Study 19726643 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 9012705 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 9012705 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 3303785 — Surrogate Endpoint (SUR): Blood pressure
Study 3303785 — Surrogate Endpoint (SUR): Serum creatinine
Study 17409891 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 28528561 — Surrogate Endpoint (SUR): Blood pressure
Study 16327016 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16327016 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 12218779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22241289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22241289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9569054 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 2146272 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 2146272 — Surrogate Endpoint (SUR): Blood pressure
Study 15064100 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 15064100 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15064100 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11777965 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 1907566 — Surrogate Endpoint (SUR): Forced vital capacity
Study 27807040 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study 26272782 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 9378845 — Surrogate Endpoint (SUR): Blood pressure
Study 30165984 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 25277740 — Surrogate Endpoint (SUR): Blood pressure
Study 11833038 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 11833038 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 7720153 — Surrogate Endpoint (SUR): Blood pressure
Study 28922068 — Surrogate Endpoint (SUR): Blood pressure
Study 26478977 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 23340005 — Surrogate Endpoint (SUR): Serum testosterone
Study 29630702 — Surrogate Endpoint (SUR): Blood pressure
Study 18486739 — Safety Biomarker (SAF): Interleukin 12
Study 8706290 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 31134632 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 29166972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22303701 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study 11344201 — Surrogate Endpoint (SUR): Bone mineral density
Study 29065052 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 29065052 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31634648 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25813214 — Surrogate Endpoint (SUR): Blood pressure
Study 11504983 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 14607627 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 10211846 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 10211846 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 31911261 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 18579901 — Surrogate Endpoint (SUR): Bone mineral density
Study 3829464 — Surrogate Endpoint (SUR): Blood pressure
Study 29360661 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 26914104 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 18504081 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 12617378 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 23095934 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 11978277 — Surrogate Endpoint (SUR): Bone mineral density
Study 8444411 — Monitoring Biomarker (MOI): HBV DNA
Study 24895285 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 18411236 — Surrogate Endpoint (SUR): Urinary oxalate
Study 27351077 — Surrogate Endpoint (SUR): Blood pressure
Study 23572200 — Surrogate Endpoint (SUR): Blood pressure
Study 3907790 — Surrogate Endpoint (SUR): Blood pressure
Study 14564683 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 21860562 — Surrogate Endpoint (SUR): Bone mineral density
Study 30318066 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 23095336 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 16837886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16837886 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 16837886 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 16837886 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 16837886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16837886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16837886 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16837886 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10872641 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study 27671673 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study 15322598 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15322598 — Surrogate Endpoint (SUR): Serum creatinine
Study 9290119 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9290119 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 23124781 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 23124781 — Surrogate Endpoint (SUR): Blood pressure
Study 16505207 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16505207 — Surrogate Endpoint (SUR): Blood pressure
Study 16505207 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 16505207 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19876062 — Surrogate Endpoint (SUR): Blood pressure
Study 31075187 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 17452537 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 17452537 — Surrogate Endpoint (SUR): Blood pressure
Study 15250647 — Surrogate Endpoint (SUR): Blood pressure
Study 8469820 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8469820 — Surrogate Endpoint (SUR): Blood pressure
Study 21584948 — Surrogate Endpoint (SUR): Blood pressure
Study 21584948 — Surrogate Endpoint (SUR): Serum potassium
Study 14689372 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 14689372 — Surrogate Endpoint (SUR): Blood pressure
Study 9183594 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 24865132 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 24304605 — Surrogate Endpoint (SUR): Serum triglycerides
Study 21423000 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 18176174 — Surrogate Endpoint (SUR): Bone mineral density
Study 15167602 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 25139884 — Surrogate Endpoint (SUR): Serum calcium
Study 21785860 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 7656936 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1155428 — Surrogate Endpoint (SUR): Blood pressure
Study 19231993 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 19231993 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19231993 — Monitoring Biomarker (MOI): HBV DNA
Study 25277272 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 9288408 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 28692641 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18436083 — Surrogate Endpoint (SUR): Blood pressure
Study 12893983 — Predictive Biomarker (PRD): GNB3 mRNA
Genes: GNB3
Study 15780739 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28504921 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 28504921 — Surrogate Endpoint (SUR): Serum triglycerides